Logo image of NBR

NABORS INDUSTRIES LTD (NBR) Stock Fundamental Analysis

NYSE:NBR - BMG6359F1370 - Common Stock

35.33 USD
-1.75 (-4.72%)
Last: 9/3/2025, 8:04:00 PM
35.33 USD
0 (0%)
After Hours: 9/3/2025, 8:04:00 PM
Fundamental Rating

2

Overall NBR gets a fundamental rating of 2 out of 10. We evaluated NBR against 61 industry peers in the Energy Equipment & Services industry. NBR has a bad profitability rating. Also its financial health evaluation is rather negative. NBR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year NBR has reported negative net income.
NBR had a positive operating cash flow in the past year.
NBR had negative earnings in each of the past 5 years.
In the past 5 years NBR always reported a positive cash flow from operatings.
NBR Yearly Net Income VS EBIT VS OCF VS FCFNBR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

With a Return On Assets value of -2.74%, NBR is not doing good in the industry: 75.41% of the companies in the same industry are doing better.
With a Return On Equity value of -44.87%, NBR is not doing good in the industry: 88.52% of the companies in the same industry are doing better.
NBR has a worse Return On Invested Capital (4.14%) than 65.57% of its industry peers.
The Average Return On Invested Capital over the past 3 years for NBR is below the industry average of 8.01%.
The 3 year average ROIC (3.54%) for NBR is below the current ROIC(4.14%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -2.74%
ROE -44.87%
ROIC 4.14%
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
NBR Yearly ROA, ROE, ROICNBR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

The Operating Margin of NBR (7.56%) is comparable to the rest of the industry.
Looking at the Gross Margin, with a value of 40.56%, NBR belongs to the top of the industry, outperforming 80.33% of the companies in the same industry.
NBR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 7.56%
PM (TTM) N/A
GM 40.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
NBR Yearly Profit, Operating, Gross MarginsNBR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), NBR is destroying value.
Compared to 1 year ago, NBR has more shares outstanding
Compared to 5 years ago, NBR has more shares outstanding
Compared to 1 year ago, NBR has an improved debt to assets ratio.
NBR Yearly Shares OutstandingNBR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M
NBR Yearly Total Debt VS Total AssetsNBR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B

2.2 Solvency

Based on the Altman-Z score of 0.37, we must say that NBR is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 0.37, NBR is doing worse than 83.61% of the companies in the same industry.
NBR has a Debt/Equity ratio of 8.68. This is a high value indicating a heavy dependency on external financing.
NBR has a worse Debt to Equity ratio (8.68) than 91.80% of its industry peers.
Industry RankSector Rank
Debt/Equity 8.68
Debt/FCF N/A
Altman-Z 0.37
ROIC/WACC0.57
WACC7.24%
NBR Yearly LT Debt VS Equity VS FCFNBR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B 4B

2.3 Liquidity

A Current Ratio of 1.79 indicates that NBR should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.79, NBR is doing worse than 62.30% of the companies in the same industry.
NBR has a Quick Ratio of 1.63. This is a normal value and indicates that NBR is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NBR (1.63) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.79
Quick Ratio 1.63
NBR Yearly Current Assets VS Current LiabilitesNBR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

More info and screens

3

3. Growth

3.1 Past

NBR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.20%, which is quite impressive.
NBR shows a small growth in Revenue. In the last year, the Revenue has grown by 3.49%.
NBR shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -0.76% yearly.
EPS 1Y (TTM)36.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.83%
Revenue 1Y (TTM)3.49%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%14.17%

3.2 Future

Based on estimates for the next years, NBR will show a very strong growth in Earnings Per Share. The EPS will grow by 28.32% on average per year.
NBR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.95% yearly.
EPS Next Y74.75%
EPS Next 2Y31.41%
EPS Next 3Y28.32%
EPS Next 5YN/A
Revenue Next Year10.29%
Revenue Next 2Y6.42%
Revenue Next 3Y5.12%
Revenue Next 5Y3.95%

3.3 Evolution

The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
NBR Yearly Revenue VS EstimatesNBR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B
NBR Yearly EPS VS EstimatesNBR Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 50 -50 -100

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

NBR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NBR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
NBR Price Earnings VS Forward Price EarningsNBR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, NBR is valued cheaper than 95.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 3.28
NBR Per share dataNBR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

NBR's earnings are expected to grow with 28.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y31.41%
EPS Next 3Y28.32%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for NBR!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

NABORS INDUSTRIES LTD

NYSE:NBR (9/3/2025, 8:04:00 PM)

After market: 35.33 0 (0%)

35.33

-1.75 (-4.72%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryEnergy Equipment & Services
Earnings (Last)07-29 2025-07-29/amc
Earnings (Next)10-20 2025-10-20/amc
Inst Owners80.33%
Inst Owner Change14.57%
Ins Owners4.01%
Ins Owner Change2.89%
Market Cap556.09M
Analysts50
Price Target39.27 (11.15%)
Short Float %15.17%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.01
Dividend Growth(5Y)-73.53%
DP-4.38%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.61%
Min EPS beat(2)-152.11%
Max EPS beat(2)171.33%
EPS beat(4)1
Avg EPS beat(4)-88.76%
Min EPS beat(4)-287.9%
Max EPS beat(4)171.33%
EPS beat(8)1
Avg EPS beat(8)-866.82%
EPS beat(12)3
Avg EPS beat(12)-678.17%
EPS beat(16)3
Avg EPS beat(16)-518.86%
Revenue beat(2)1
Avg Revenue beat(2)-0.09%
Min Revenue beat(2)-2.41%
Max Revenue beat(2)2.22%
Revenue beat(4)1
Avg Revenue beat(4)-0.74%
Min Revenue beat(4)-2.41%
Max Revenue beat(4)2.22%
Revenue beat(8)2
Avg Revenue beat(8)-1.17%
Revenue beat(12)4
Avg Revenue beat(12)-0.79%
Revenue beat(16)7
Avg Revenue beat(16)-0.38%
PT rev (1m)4.05%
PT rev (3m)-19.55%
EPS NQ rev (1m)-10.73%
EPS NQ rev (3m)9.58%
EPS NY rev (1m)-8.67%
EPS NY rev (3m)-8.67%
Revenue NQ rev (1m)-1.83%
Revenue NQ rev (3m)3.35%
Revenue NY rev (1m)-1.09%
Revenue NY rev (3m)-2.61%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.18
P/FCF N/A
P/OCF 1.05
P/B 1.81
P/tB 1.81
EV/EBITDA 3.28
EPS(TTM)-11.35
EYN/A
EPS(NY)-5.36
Fwd EYN/A
FCF(TTM)-9.38
FCFYN/A
OCF(TTM)33.8
OCFY95.68%
SpS192.54
BVpS19.57
TBVpS19.57
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -2.74%
ROE -44.87%
ROCE 5.24%
ROIC 4.14%
ROICexc 4.55%
ROICexgc 4.55%
OM 7.56%
PM (TTM) N/A
GM 40.56%
FCFM N/A
ROA(3y)-4.38%
ROA(5y)-7.78%
ROE(3y)-88.52%
ROE(5y)-87.38%
ROIC(3y)3.54%
ROIC(5y)N/A
ROICexc(3y)4.37%
ROICexc(5y)N/A
ROICexgc(3y)4.37%
ROICexgc(5y)N/A
ROCE(3y)4.47%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.82%
GM growth 5Y2.06%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 8.68
Debt/FCF N/A
Debt/EBITDA 3.06
Cap/Depr 105.35%
Cap/Sales 22.43%
Interest Coverage 250
Cash Conversion 60.85%
Profit Quality N/A
Current Ratio 1.79
Quick Ratio 1.63
Altman-Z 0.37
F-Score5
WACC7.24%
ROIC/WACC0.57
Cap/Depr(3y)76.54%
Cap/Depr(5y)57.36%
Cap/Sales(3y)17.15%
Cap/Sales(5y)14.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)36.2%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.83%
EPS Next Y74.75%
EPS Next 2Y31.41%
EPS Next 3Y28.32%
EPS Next 5YN/A
Revenue 1Y (TTM)3.49%
Revenue growth 3Y13.25%
Revenue growth 5Y-0.76%
Sales Q2Q%14.17%
Revenue Next Year10.29%
Revenue Next 2Y6.42%
Revenue Next 3Y5.12%
Revenue Next 5Y3.95%
EBIT growth 1Y-5.25%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year272.6%
EBIT Next 3Y62.37%
EBIT Next 5Y41.73%
FCF growth 1Y-179.67%
FCF growth 3Y-58.66%
FCF growth 5Y-44.51%
OCF growth 1Y-19.55%
OCF growth 3Y10.68%
OCF growth 5Y-3.21%